Side-by-side comparison
LL-37 Truncated Variants (KR-12 / KS-30) vs Anamorelin
Shorter active fragments of LL-37 (KR-12, KS-30) with retained antimicrobial activity but lower toxicity. versus Oral ghrelin-receptor agonist developed for cancer cachexia; approved in Japan as Adlumiz.
LL-37 Truncated Variants (KR-12 / KS-30)
RecoveryShorter active fragments of LL-37 (KR-12, KS-30) with retained antimicrobial activity but lower toxicity.
Top benefits
- ✓Antimicrobial activity preserved
- ✓Lower hemolysis vs full LL-37
- ✓Wound healing research
Anamorelin
PerformanceOral ghrelin-receptor agonist developed for cancer cachexia; approved in Japan as Adlumiz.
Top benefits
- ✓Increases lean body mass
- ✓Improves appetite
- ✓Oral bioavailability
| Attribute | LL-37 Truncated Variants (KR-12 / KS-30) | Anamorelin |
|---|---|---|
| Category | Recovery | Performance |
| Type | linear | small-molecule |
| Chain length | 12 aa | 1 aa |
| Formula | KR-12 fragment of LL-37 | C31H42N6O3 |
| Common dose | Not established | 100 mg |
| Frequency | N/A | Daily, oral |
| Top benefit | Antimicrobial activity preserved | Increases lean body mass |
| Top side-effect | Localized irritation (topical) | Hyperglycemia |
⚠
Educational use only
This calculator is provided for research and educational purposes. Outputs are derived from the values you enter. Always verify your math and consult a licensed physician before acting on any result.